AKRO logo

Akero Therapeutics, Inc. (AKRO) Net income

annual net income:

-$252.06M-$100.30M(-66.09%)
December 31, 2024

Summary

  • As of today (September 16, 2025), AKRO annual net profit is -$252.06 million, with the most recent change of -$100.30 million (-66.09%) on December 31, 2024.
  • During the last 3 years, AKRO annual net income has fallen by -$151.28 million (-150.12%).
  • AKRO annual net income is now -5422.79% below its all-time high of -$4.56 million, reached on December 31, 2017.

Performance

AKRO Net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

quarterly net income:

-$70.50M+$220.00K(+0.31%)
June 30, 2025

Summary

  • As of today (September 16, 2025), AKRO quarterly net profit is -$70.50 million, with the most recent change of +$220.00 thousand (+0.31%) on June 30, 2025.
  • Over the past year, AKRO quarterly net income has dropped by -$14.52 million (-25.93%).
  • AKRO quarterly net income is now -16647.03% below its all-time high of -$421.00 thousand, reached on March 31, 2018.

Performance

AKRO quarterly net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

TTM net income:

-$283.96M-$14.52M(-5.39%)
June 30, 2025

Summary

  • As of today (September 16, 2025), AKRO TTM net profit is -$283.96 million, with the most recent change of -$14.52 million (-5.39%) on June 30, 2025.
  • Over the past year, AKRO TTM net income has dropped by -$79.78 million (-39.08%).
  • AKRO TTM net income is now -52002.57% below its all-time high of -$545.00 thousand, reached on December 1, 2017.

Performance

AKRO TTM net income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherAKROincome statement metrics

Net income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

AKRO Net income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-66.1%-25.9%-39.1%
3 y3 years-150.1%-157.3%-157.7%
5 y5 years-476.1%-335.0%-379.2%

AKRO Net income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-150.1%at low-205.8%+3.0%-157.7%at low
5 y5-year-476.1%at low-367.2%+3.0%-379.2%at low
alltimeall time-5422.8%at low<-9999.0%+3.0%<-9999.0%at low

AKRO Net income History

DateAnnualQuarterlyTTM
Jun 2025
-
-$70.50M(-0.3%)
-$283.96M(+5.4%)
Mar 2025
-
-$70.72M(+1.0%)
-$269.44M(+6.9%)
Dec 2024
-$252.06M(+66.1%)
-$70.02M(-3.7%)
-$252.06M(+6.3%)
Sep 2024
-
-$72.70M(+29.9%)
-$237.22M(+16.2%)
Jun 2024
-
-$55.99M(+5.0%)
-$204.18M(+13.9%)
Mar 2024
-
-$53.34M(-3.3%)
-$179.27M(+18.1%)
Dec 2023
-$151.76M(+35.5%)
-$55.19M(+39.2%)
-$151.76M(+26.9%)
Sep 2023
-
-$39.66M(+27.6%)
-$119.63M(+3.6%)
Jun 2023
-
-$31.08M(+20.3%)
-$115.52M(+3.3%)
Mar 2023
-
-$25.83M(+12.0%)
-$111.83M(-0.2%)
Dec 2022
-$112.03M(+11.2%)
-$23.06M(-35.1%)
-$112.03M(-7.7%)
Sep 2022
-
-$35.54M(+29.7%)
-$121.40M(+10.2%)
Jun 2022
-
-$27.40M(+5.3%)
-$110.19M(-1.4%)
Mar 2022
-
-$26.03M(-19.7%)
-$111.72M(+10.9%)
Dec 2021
-$100.78M
-$32.42M(+33.3%)
-$100.78M(+2.8%)
Sep 2021
-
-$24.33M(-15.9%)
-$98.06M(+3.1%)
DateAnnualQuarterlyTTM
Jun 2021
-
-$28.93M(+91.7%)
-$95.14M(+15.4%)
Mar 2021
-
-$15.09M(-49.2%)
-$82.41M(+4.0%)
Dec 2020
-$79.21M(+81.0%)
-$29.71M(+38.8%)
-$79.21M(+21.7%)
Sep 2020
-
-$21.40M(+32.1%)
-$65.11M(+9.9%)
Jun 2020
-
-$16.21M(+36.4%)
-$59.26M(+17.9%)
Mar 2020
-
-$11.89M(-23.9%)
-$50.28M(+14.9%)
Dec 2019
-$43.76M(-46.5%)
-$15.61M(+0.4%)
-$43.76M(-51.2%)
Sep 2019
-
-$15.55M(+115.2%)
-$89.62M(+5.2%)
Jun 2019
-
-$7.23M(+34.8%)
-$85.21M(-1.7%)
Mar 2019
-
-$5.36M(-91.3%)
-$86.66M(+6.0%)
Dec 2018
-$81.71M(+1690.4%)
-$61.47M(+451.4%)
-$81.71M(+293.1%)
Sep 2018
-
-$11.15M(+28.5%)
-$20.79M(+115.7%)
Jun 2018
-
-$8.67M(+1960.1%)
-$9.64M(+897.8%)
Mar 2018
-
-$421.00K(-22.8%)
-$966.00K(+77.2%)
Dec 2017
-$4.56M
-
-
Dec 2017
-
-$545.00K
-$545.00K

FAQ

  • What is Akero Therapeutics, Inc. annual net profit?
  • What is the all time high annual net income for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. annual net income year-on-year change?
  • What is Akero Therapeutics, Inc. quarterly net profit?
  • What is the all time high quarterly net income for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. quarterly net income year-on-year change?
  • What is Akero Therapeutics, Inc. TTM net profit?
  • What is the all time high TTM net income for Akero Therapeutics, Inc.?
  • What is Akero Therapeutics, Inc. TTM net income year-on-year change?

What is Akero Therapeutics, Inc. annual net profit?

The current annual net income of AKRO is -$252.06M

What is the all time high annual net income for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high annual net profit is -$4.56M

What is Akero Therapeutics, Inc. annual net income year-on-year change?

Over the past year, AKRO annual net profit has changed by -$100.30M (-66.09%)

What is Akero Therapeutics, Inc. quarterly net profit?

The current quarterly net income of AKRO is -$70.50M

What is the all time high quarterly net income for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high quarterly net profit is -$421.00K

What is Akero Therapeutics, Inc. quarterly net income year-on-year change?

Over the past year, AKRO quarterly net profit has changed by -$14.52M (-25.93%)

What is Akero Therapeutics, Inc. TTM net profit?

The current TTM net income of AKRO is -$283.96M

What is the all time high TTM net income for Akero Therapeutics, Inc.?

Akero Therapeutics, Inc. all-time high TTM net profit is -$545.00K

What is Akero Therapeutics, Inc. TTM net income year-on-year change?

Over the past year, AKRO TTM net profit has changed by -$79.78M (-39.08%)
On this page